{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Unichem Laboratories Ltd
Is Unichem Labs. technically bullish or bearish?
As of November 12, 2025, Unichem Labs is in a bearish trend with moderate strength, driven by bearish daily moving averages and signals from the weekly KST and Dow Theory, despite some mildly bullish indicators.
Is Unichem Labs. overvalued or undervalued?
As of November 12, 2025, Unichem Labs. is considered attractive and undervalued compared to peers like Sun Pharma and Cipla, with a PE ratio of 22.88 and a strong 5-year return of 105.39%, despite recent stock performance lagging behind the Sensex.
Unichem Laboratories Faces Mixed Technical Trends Amid Market Challenges and Resilience
Unichem Laboratories, a small-cap pharmaceutical company, has faced significant challenges over the past year, with a notable decline in stock performance compared to the broader market. Despite recent technical indicators suggesting bearish sentiment, the company has shown resilience with strong long-term returns, indicating potential for strategic improvements.
How has been the historical performance of Unichem Labs.?
Unichem Labs has shown significant recovery and growth, with net sales increasing from 1,125.01 crore in March 2020 to 2,110.97 crore in March 2025, and a turnaround in profitability, achieving a profit after tax of 137.52 crore in March 2025 after previous losses. Despite rising total liabilities and negative cash flow from operating activities, the company has demonstrated resilience in its financial performance.
Unichem Laboratories Faces Mixed Technical Trends Amid Market Volatility
Unichem Laboratories, a small-cap pharmaceutical company, has experienced significant volatility, with its stock recently priced at 484.90. Over the past year, it has faced a notable decline, contrasting with the Sensex's modest gains. Technical indicators present a mixed outlook, reflecting caution amid fluctuating market dynamics.
Are Unichem Labs. latest results good or bad?
Unichem Laboratories' latest results show a 14.11% increase in net sales year-on-year, but the company reported a net loss of ₹11.89 crores, highlighting ongoing profitability challenges despite improved operational efficiency. Overall, the performance is concerning, especially given a significant stock decline of 44.90% over the past year.
Unichem Laboratories Q2 FY26: Losses Deepen Amid Operational Challenges
Unichem Laboratories Ltd. reported a consolidated net loss of ₹11.89 crores for Q2 FY26, marking the company's second consecutive quarter of losses and representing a sharp deterioration from a profit of ₹24.63 crores in the corresponding quarter last year. The Mumbai-based pharmaceutical manufacturer's stock plunged 5.10% following the results announcement, reflecting investor concerns over the company's operational challenges despite revenue growth of 14.11% year-on-year to ₹578.96 crores.
Unichem Laboratories Hits New 52-Week Low at Rs. 438.5
Unichem Laboratories has reached a 52-week low of Rs. 438.5, despite showing some resilience by outperforming its sector. The stock peaked at Rs. 490.1 during intraday trading. Over the past year, it has faced significant challenges, with a notable decline in performance compared to the broader market.
Is Unichem Labs. technically bullish or bearish?
As of November 7, 2025, Unichem Labs is in a bearish trend with moderate strength, indicated by bearish MACD, Bollinger Bands, and moving averages, despite a bullish weekly RSI.
Unichem Laboratories Faces Technical Challenges Amidst Market Dynamics and Bearish Sentiment
Unichem Laboratories has recently revised its stock evaluation amid challenging market conditions. Currently priced at 461.50, the stock has seen a significant decline over the past year, with a return of -47.89%. Technical indicators suggest a bearish sentiment, reflecting ongoing difficulties in the competitive pharmaceutical sector.
Is Unichem Labs. technically bullish or bearish?
As of November 7, 2025, Unichem Labs exhibits a bearish trend with moderate strength, driven by bearish indicators across multiple time frames, despite a mildly bullish OBV on the weekly chart.
Is Unichem Labs. technically bullish or bearish?
As of November 7, 2025, Unichem Labs is in a bearish trend with moderate strength, driven by bearish indicators from the weekly MACD, Bollinger Bands, and daily moving averages, despite some bullish divergence in the weekly RSI.
Why is Unichem Labs. falling/rising?
As of 07-Nov, Unichem Laboratories Ltd's stock price is Rs. 461.50, down 1.65%, and has reached a 52-week low of Rs. 455. The company has underperformed significantly over the past year and month, with a 47.89% drop in returns and a low return on equity, despite increased investor participation.
Unichem Laboratories Hits New 52-Week Low at Rs. 455
Unichem Laboratories has reached a 52-week low, reflecting a significant decline in its stock performance. The company has underperformed its sector and is trading below key moving averages. Financial metrics indicate low profitability and challenges, prompting close scrutiny from market participants as it navigates this downturn.
Unichem Laboratories Faces Mixed Technical Signals Amid Market Evaluation Revision
Unichem Laboratories, a small-cap pharmaceutical company, has faced significant challenges, with a one-year return of -44.87%. Despite a recent stock price increase, technical indicators show mixed signals. Year-to-date performance remains weak, though a five-year return of 95.95% indicates some resilience compared to broader market trends.
Unichem Laboratories Hits New 52-Week Low at Rs. 455.25
Unichem Laboratories has reached a 52-week low, reflecting a decline in its stock performance, which has underperformed the sector. The company is trading below various moving averages, and its one-year performance shows a significant drop. Despite these challenges, it maintains a low debt-to-equity ratio and a modest return on capital employed.
Why is Unichem Labs. falling/rising?
As of 06-Oct, Unichem Laboratories Ltd's stock price is Rs 487.70, down 0.74%, and has underperformed its sector. Despite a recent short-term gain of +3.33%, the stock has significant long-term declines, raising concerns about profitability and market sentiment.
Is Unichem Labs. overvalued or undervalued?
As of October 1, 2025, Unichem Labs. is considered very attractive and undervalued, with favorable valuation ratios compared to peers, despite a year-to-date stock performance lagging behind the Sensex.
Is Unichem Labs. overvalued or undervalued?
As of October 1, 2025, Unichem Labs is considered undervalued with a very attractive valuation grade, featuring a PE ratio of 27.22 and an EV to EBITDA of 15.15, making it a compelling investment opportunity compared to its more expensive peers like Sun Pharma and Divi's Lab.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
